If you have Crohn's consider taking part in the Etro Study.
WHY PARTICIPATE IN A CLINCIAL TRIAL?
You may get expert medical care from leading specialists and nurses throughout the study
You remain in control of your level of participation
You contribute to scientific understanding of Crohn's
Multiple Dose of Oral Capsules in Participants with Mild to Moderate Ulcerative Colitis.
You may qualify for this study if you meet criteria:
*other eligibility criteria may apply
you may be compensated for time and travel.
You know what it's like to live with Ulcerative Colitis...
The discomfort it causes physically and the toll it can take on you mentally...always making you wonder "WHAT IF?"
"What if I need to find a bathroom?" "What if there is a line?"
A global research study of an investigational medication hoped to treat the symptoms in those with Ulcerative Colitis for at least the past three months.
Qualified participants will receive all study related care and medication at no cost.
So if you are living with UC in a constant state of -
"What if..." I Flare Up?
Then please learn more about this study opportunity.
If you have Crohn's disease and have completed induction therapy with anti-TNF therapy within the past 24 weeks you may qualify for a study using a nutritional supplement (orally administered medical food).
*You may be compensated for time and travel.
Borland-Groover Clinic is conducting a study that is comparing two different methods of colonoscopy screenings. The methods include a "pillcam" capsule endoscopy versus a virtual colonoscopy (imaging study with a CT scan). The results will be confirmed by a traditional colonoscopy.
All testing and procedures done for this study will be provided at no cost. Compensation is available for qualified participants.
Help us open the door to a potential new treatment option for patients with Crohn's disease.
If you have Crohn's disease, you may be able to join a new research study. Will you help us?
Are you living with Crohn's disease (CD)? We are looking for patients with CD to take part in a research study caaled VOLTAIRE-CD. The VOLTAIRE Study is looking at how safe and effective an investigational medication is when given to patients with CD.
You may be able to take part in this study if you, at a minimun:
* are 18-80 years of age
* were diagnosed more than 4 months ago with moderate to severe CD and still sometimes have flares.
Please contact us if you think you may be able to take part in, or if you are interested in learning more about, the VOLTAIRE-CD Study. We will be happy to answer any questions that you may have.
YOU MAY QUALIFY IF: